Practice and thoughts on vaccine resident inspection in Shanghai
Expand
1Shanghai Center for Drug Evaluation and Inspection, Shanghai 201210, China;2Shanghai Municipal Drug Administration, Shanghai 200233, China;3Shanghai Institute for Drug Control,Shanghai 201210,China
Five years after the implementation of vaccine resident inspection system, it has achieved remarkable results in ensuring the bottom line of vaccine safety production and improving the GMP compliance level of enterprises.With China’s deep participation in the international drug regulatory system, such as International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and Pharmaceutical Inspection Co-operation Scheme, the current inspection mechanism needs further consideration and improvement in terms of international integration and professional capacity building. Based on the practice and development of the “four-in-one” collaborative supervision mode of vaccine resident inspection in Shanghai, this paper discusses the internationalization of benchmarking, careful organization and implementation of resident inspection, highlighting the key points of resident inspection and optimizing resident inspection strategies, aiming at building a more scientific and efficient vaccine quality supervision system and continuously improving the supervision efficiency.